Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)

The French Tuberculosis Cohort is a prospective, national, multicenter, low-intervention study including subjects aged 18 years and older with tuberculosis disease for which inpatient treatment is initiated. The goal of this observational study is to follow-up and anti-tuberculosis treatment will be provided according to current French recommendations. Participants will provide sociodemographic, clinical, biological, radiological and bacteriological data at various protocol visits at 2 days, 1 and 2 weeks, 2 months, at the end of treatment, 12 and 24 months. Consenting participants will have samples collected at scheduled visits for the establishment of a biobank. This will include blood, urine, breath and hair samples. The positive mycobacterial strains will constitute a specimen bank.

NCT Number	NCT06893757
Lead Sponsor	ANRS, Emerging Infectious Diseases Collaborators: University of Bordeaux, Amiens University Hospital, Centre National de la Recherche Scientifique, France, Saint Antoine University Hospital, University of Lyon, Claude Bernard University, University Hospital, Bordeaux, Saint-Louis Hospital, Paris, France, Centre Hospitalier Universitaire, Amiens, Hôpital Jean Verdier, Institut National de la Santé Et de la Recherche Médicale, France
Conditions	Tuberculosis
Enrollment	2,000 participants
Start Date	2026-05-06
Primary Completion	2027-06 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-12